NEW YORK ─ An Australian research team is developing a DNA-based saliva test that it believes could one day become a screening tool to detect hidden oropharyngeal cancers in patients that are asymptomatic.
Reporting their findings recently in Frontiers in Oncology, the researchers said that they used an internally developed molecular assay to conduct serial measurements of HPV-16 DNA in the saliva of 650 study participants.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
